Helicobacter pylori eradication with either quadruple regimen with lactoferrin or levofloxacin-based triple therapy: a multicentre study

Cesare Hassan, A Zullo, V De Francesco, G Scaccianoce, G Manes, C Efrati, G Maconi, D Piglionica, C Cannaviello, C Panella, S Morini, E. Ierardi

Risultato della ricerca: Contributo in rivistaArticolo in rivista

28 Citazioni (Scopus)

Abstract

Helicobacter pylori eradication rate following standard triple therapy is decreasing worldwide. A quadruple therapy with lactoferrin and a levofloxacin-based triple therapy has been found to achieve a very high (>90%) cure rate. This study aimed to confirm these encouraging results.
Lingua originaleEnglish
pagine (da-a)806-810
Numero di pagine5
RivistaDIGESTIVE AND LIVER DISEASE
Volume39
DOI
Stato di pubblicazionePubblicato - 2007
Pubblicato esternamenteYes

Keywords

  • 2-Pyridinylmethylsulfinylbenzimidazoles
  • Adult
  • Amoxicillin
  • Anti-Bacterial Agents
  • Clarithromycin
  • Drug Therapy, Combination
  • Female
  • Helicobacter Infections
  • Helicobacter pylori
  • Humans
  • Lactoferrin
  • Male
  • Middle Aged
  • Ofloxacin
  • Tinidazole
  • Treatment Outcome

Fingerprint Entra nei temi di ricerca di 'Helicobacter pylori eradication with either quadruple regimen with lactoferrin or levofloxacin-based triple therapy: a multicentre study'. Insieme formano una fingerprint unica.

Cita questo